The development of a heterologous transfusion technique: application to sickle cell disease.
D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000097:blood / Q000188:drug therapy / Q000628:therapy*; D000818:Animals; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D003169:Complement Inactivator Proteins; D003485:Cyanates / Q000627:therapeutic use; D004195:Disease Models, Animal; D004905:Erythrocyte Aging; D004912:Erythrocytes / Q000276:immunology*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D012157:Mononuclear Phagocyte System / Q000502:physiology; D051381:Rats; D012911:Snakes; D013154:Spleen / Q000502:physiology; D014183:Transplantation, Heterologous; D014688:Venoms / Q000494:pharmacology
D003169:Complement Inactivator Proteins; D003485:Cyanates; D014688:Venoms